Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-22-085617

Chief Financial Officer acquired 1,366 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Eisenstadt Richard I · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-07-31 Grant or award : show line 1 in the form +1,366 $6.86 $9,371 1,366 D
Loading xslF345X03/tm2222488-1_4seq1.xml…